Published the monthly exercise status for Series 22 stock acquisition rights (with exercise price adjustment clause) for September 2026. Number of shares granted: 210,000 shares; number of exercised rights: 2,100; exercise ratio to total issued shares: 0.57%; unexercised at month-end: 252,470 shares (previous month-end included 32,329 shares of treasury stock).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4571","jir_company_name":"Nano Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4571-20261001-01.pdf","jir_short_summary":"Published the monthly exercise status for Series 22 stock acquisition rights (with exercise price adjustment clause) for September 2026. Number of shares granted: 210,000 shares; number of exercised rights: 2,100; exercise ratio to total issued shares: 0.57%; unexercised at month-end: 252,470 shares (previous month-end included 32,329 shares of treasury stock).","jir_summary":"### Exercise Status of Stock Acquisition Rights\nNano Holdings, Inc. published the monthly exercise status for Series 22 stock acquisition rights (with exercise price adjustment clause) for September 2026. The number of shares granted for the month was 210,000 shares; rights exercised during the month totaled 2,100 units, representing an exercise ratio of 0.57% to the total issued shares. Unexercised rights decreased from 252,470 units to 250,370 units by month-end. The number of paid-in shares, as stated in the disclosed materials, shows an exercise restriction ratio of 0.29% against the total issued shares of 71,981,758 shares.\n\n### Future Impact and Background\nThese stock acquisition rights include an exercise price adjustment clause, and monthly exercise trends may indicate potential dilution; however, the monthly exercised volume this period is low relative to the total issued shares. The decrease in unexercised rights from the previous month may affect future issuance volume and dilution of treasury stock depending on ongoing exercise trends. Detailed background and future schedules refer to past press releases, and related matters such as third-party allotments are cited.","jir_financial_highlights":"Number of shares granted: 210,000 shares (Unknown)\nNumber of stock acquisition rights exercised: 2,100 units (Unknown)\nExercise ratio to total issued shares: 0.57% (Unknown)\nNumber of unexercised stock acquisition rights (previous month-end): 252,470 units (Unknown)\nNumber of unexercised stock acquisition rights (month-end): 250,370 units (Unknown)","jir_category":"","jir_hashtags":"#NanoHoldings, #StockAcquisitionRights, #ExerciseStatus","jir_key_figures":"Number of shares granted: 210,000 shares\nNumber of stock acquisition rights exercised: 2,100 units\nExercise ratio to total issued shares: 0.57%","jir_meta_title":"Nano Holdings, Inc. Announces Monthly Exercise Status of Stock Acquisition Rights | September 2026","jir_meta_description":"Nano Holdings, Inc. discloses the September 2026 monthly exercise status for Series 22 stock acquisition rights: 210,000 shares granted, 2,100 rights exercised, 0.57% exercise ratio, and 250,370 unexercised rights. Monitor dilution risk trends.","jir_og_title":"Nano Holdings, Inc. Announces Monthly Exercise Status of Stock Acquisition Rights | September 2026","jir_og_description":"Nano Holdings, Inc. disclosed the September monthly exercise status of stock acquisition rights: 210,000 shares granted, 2,100 exercised, 0.57% exercise ratio, and 250,370 unexercised rights.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58963,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-126490","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n